Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
12,407,695
-
Share change
-
+1,278
-
Total reported value
-
$99,384,397
-
Price per share
-
$8.01
-
Number of holders
-
48
-
Value change
-
+$10,303
-
Number of buys
-
1
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2013
As of 31 Dec 2013,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,407,695 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, Visium Asset Management, LP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and BlackRock Fund Advisors.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.